Genasys pushes $15.2M term loan maturity to 2027, layering on a 20% minimum return and monthly amortization
GNSS sits 21% above its 52-week low of $1.4.
Summary
Genasys extended its $15.2M term loan maturity to July 2027, but added a 20% guaranteed minimum return and mandatory $1M monthly principal payments starting October 2026, significantly increasing the cost of capital.
Key Events · Financing and Capital Events · GNSS
-
Loan Maturity Extended to 2027
The $15.2M term loan maturity was pushed from July 13, 2026 to July 13, 2027, avoiding immediate default but adding costly new terms.
-
20% Minimum Return (MOIC) Added
A guaranteed minimum return of 20% was added on top of the existing SOFR+5% interest, significantly increasing the effective cost of the debt.
-
Mandatory $1M Monthly Payments
Starting October 1, 2026, Genasys must make monthly payments of $1 million toward principal and MOIC, replacing the prior balloon payment structure.
-
Warrant Terms Sweetened for Lenders
The warrant exercise price was reduced from $2.53 to $2.28 per share, and the exercise period was extended by one year to May 13, 2030.
Analysis · GNSS · Manufacturing
By amending its existing term loan, Genasys bought itself an extra year—pushing maturity to July 2027—but at a steep price. The revised terms layer a guaranteed 20% minimum return (MOIC) on top of SOFR+5% interest, and mandate $1 million monthly payments toward principal and MOIC starting October 2026. That replaces the old balloon structure with a forced amortization schedule that will drain $1M a month from operations. Lenders also got a sweetener: the warrant exercise price dropped from $2.53 to $2.28, and the exercise window was extended to 2030. While the extension removes near-term default risk, the high cost and aggressive repayment timeline suggest the company had limited negotiating leverage and faces significant cash flow pressure.
At the time of this filing, GNSS was trading at $1.70 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $77.4M. The 52-week trading range was $1.40 to $2.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.